Heparanase Inhibitor as Anti-Metastatic Therapy for Myeloma.

Grant

Total Award Amount

  • 75000.00
  • Direct Costs

  • 68182.00
  • Sponsor Award Id

  • Contributor

  • Ralph Sanderson Ph.D.   Principal Investigator